Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 15, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Cystic Fibrosis

Interventions

DRUG

Initiation of CFTR Modulator

Inhaled contrast for MRI occurring at each visit

DRUG

Hyperpolarized Xenon 129

Inhaled contrast for MRI occurring at each visit

Trial Locations (1)

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors

lead

Children's Hospital Medical Center, Cincinnati

OTHER